Deutsche Bank analyst George Hill raised the firm’s price target on HealthEquity (HQY) to $115 from $98 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- HealthEquity Inc. Earnings Call Highlights Growth and Legislative Wins
- HealthEquity price target raised to $125 from $100 at KeyBanc
- Morning Movers: Chart Industries, Flowserve both rise following merger pact
- HealthEquity price target raised to $117 from $112 at RBC Capital
- HealthEquity price target raised to $125 from $110 at BofA